Originally posted by Galilee13:
↑
So post the AGM big news is the UK business is up and running and in turn will help GMV be cash flow neutral by years end. 2 people have posted that annual contract value are either 250k or 500k pounds and that they have 7 customers close to signing. For this example, let's use the conservative number of 250k GBP. Company needs about $19.5m usd in revenue a year to break even. This can be achieved via: Current US IDTF is doing about $1.5m a qtr Or $6m USD a year Hygena contract is $11m USD a year. That gives us $17m USD on what has been announced so far. UK business. 250k GBP is about $320k USD. So 7 contracts would be worth about $2.3m USD per year. So all up I conservatively estimate $19.3m in annual revenues. Best of all most of this revenue is recurring and would not include many product sales. With about 500m shares on issues post Nasdaq, gives a market cap of about $80m USD. So company is trading on about 4 times revenue. Add in $15m USD cash after costs form nasdaq listing. Plus HK IPO will add another $55m USD. So potentially we could have $70m USD cash in the bank very soon or the equivalent of 20c AUD a share. Still waiting on more comments back from Yacov and HC Wainwright. So will give more thoughts later.
Expand
Hi G13
My notes recorded that Brendan stated the UK business currently has 7 accounts each worth around $250,000Gbp per annum.
Conservative numbers for this coming Qtr IMO are as follows:
USA IDTF - USD $1,400,000
Hygena - USD $270,000 (using the minimum numbers under the PO $90K per month)
UK Business - USD $557,000 (7 accounts worth $250K Gbp pa = 1,750,000Gbp pa) = USD $2,227,943 pa / 4 = $557,000 per Qtr
No fluff = USD $2,227,000 This Qtr ending 30th June 19 ( +80% on last Qtr)
JW